Services

Pharcom specialises in providing commercial strategy consultations
for pharmaceutical, biotech, and healthcare organisations.
Pharcom expertise extends from guiding teams in formulating
successful early commercialisation strategies for Phase 1 to Phase 2 assets, pre-launch and launch strategies/roadmaps for Phase 3 assets, commercial and brand strategies, market-shaping approaches, brand building, and global marketing strategies. The proven track record
includes global commercial organisation transformations, introducing successful asset leadership models like the Global Product Team for effective life cycle management.

Early Commercialisation Strategy

  • Define a compelling value proposition that meets a need for future
    market access requirements and delivers successful commercial launch.
  • Develop business cases for new assets or indication expansion for the
    existing ones.

Launch Strategy

  • Formulate cross-functional pre-launch and launch plans.
  • Develop a market-shaping initiatives with a winning agenda.
  • Guidance to build a global brand plan to maximize the launch trajectory.

Differentiation Strategy

  • Create a brand/commercial strategy with a competitive edge in a highly
    competitive environment.

Organisational Build-up and Transformation

  • Defining organisations future blueprint in collaboration with c-suite team.
    Development and transformation of a commercial organisation to best fit
    for the future opportunities.
  • Developing a brand management operational principles and roles for
    effective global, regional, and local marketing.

Case Studies

Expertise & About us

With over 20 years of hands-on experience in the pharmaceutical, biotech,
and diagnostic industries, I have held various roles—from in-market sales
and marketing to global commercial leadership. Throughout my career,
I’ve been instrumental in the successful global launch of blockbuster drugs, demonstrating expertise in developing comprehensive commercial launch
and market-shaping strategies across diverse therapeutic areas.

These areas include:

Chronic Inflammatory Diseases
building a differentiation strategy in highly invested and competed disease
areas such as Rheumatoid Arthritis (RA), Respiratory conditions
(severe asthma), and Inflammatory Bowel Disease (IBD).

Neurology
Addressing neurological conditions such as sleep disorders.

Rare Diseases
Navigating the unique opportunities and challenges
of rare disease assets commercialisation strategies.

As a seasoned pharmaceutical executive, I deeply understand the needs
and challenges of Biotech and Pharma clients. My journey through the
intricacies of the industry spans global multinational environments,
encompassing diverse geographies and cultural backgrounds—ranging
from Scandinavian to Japanese, American, Swiss, and British settings.
This extensive experience has enriched my understanding of different
company cultures and operating models.

Juhana Heinonen
Managing Director

Contact